人类白细胞抗原同种免疫的预防：白细胞去除术和紫外线B照射的作用
Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
作者信息
Snyder E L
机构信息
Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut.
出版信息
Yale J Biol Med. 1990 Sep-Oct;63(5):419-27.
Abstract
HLA alloimmunization is a major cause of the platelet refractory state. The stimulus for HLA alloimmunization is believed to derive from incompatibility between the recipient's lymphocytes and the passenger donor lymphocytes contained in transfused red cells or platelet concentrates. Two techniques to prevent post-transfusion HLA alloimmunization include filtration, which physically removes the donor lymphocytes, and UV-B irradiation, which renders the donor leukocytes biologically inactive. The role of these two techniques in the prevention of HLA alloimmunization is the focus of this review.
摘要
人类白细胞抗原（HLA）同种免疫是血小板输注无效状态的主要原因。HLA同种免疫的刺激因素据信源于受者淋巴细胞与输注的红细胞或血小板浓缩物中所含供者过客淋巴细胞之间的不相容性。预防输血后HLA同种免疫的两种技术包括过滤，即从物理上清除供者淋巴细胞，以及紫外线B（UV-B）照射，使供者白细胞失去生物学活性。这两种技术在预防HLA同种免疫中的作用是本综述的重点。
相似文献
1
Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.人类白细胞抗原同种免疫的预防：白细胞去除术和紫外线B照射的作用
Yale J Biol Med. 1990 Sep-Oct;63(5):419-27.
2
[Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].[白细胞去除血小板浓缩物预防频繁输血患者 HLA 同种免疫的疗效：一项使用聚酯血小板滤器的前瞻性多机构研究]
Rinsho Ketsueki. 1992 Apr;33(4):451-60.
3
Prevention of platelet alloimmunization.
Prog Clin Biol Res. 1986;211:83-116.
4
HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome.在患有亨特综合征的患者中，使用来自HLA匹配和HLA不匹配供体的白细胞浓缩物进行HLA同种免疫。
Ann Clin Lab Sci. 1985 Sep-Oct;15(5):435-40.
5
[Prevention of HLA-alloimmunization of recipients of platelet concentrates].[预防血小板浓缩物接受者的HLA同种免疫]
Beitr Infusionsther. 1991;28:209-12.
6
Characteristics and natural history of alloimmunization following HLA-matched leukocyte transfusion in Hunter's syndrome.
Ann Clin Lab Sci. 1984 Jul-Aug;14(4):276-84.
7
[Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Aug;33(4):412-20. doi: 10.3881/j.issn.1000-503X.2011.04.013.
8
Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets.富含白细胞或贫白细胞的随机单供者血小板引起的同种免疫。
Prog Clin Biol Res. 1990;337:45-8.
9
10
UVB irradiation of human platelet concentrates does not prevent HLA alloimmunization in recipients.对人浓缩血小板进行紫外线B照射并不能防止受者发生HLA同种免疫。
Blood. 1994 Nov 15;84(10):3524-31.
引用本文的文献
1
Human leukocyte antigen alloimmunization prevention mechanisms in blood transfusion.输血中人类白细胞抗原同种免疫的预防机制
Asian J Transfus Sci. 2023 Jul-Dec;17(2):264-272. doi: 10.4103/ajts.ajts_144_21. Epub 2022 Sep 28.
2
Associations of Perioperative Red Blood Cell Transfusion With Outcomes of Kidney Transplantation in Korea Over a 16-Year Period.韩国 16 年间围手术期输红细胞与肾移植结局的相关性研究。
J Korean Med Sci. 2023 Jul 17;38(28):e212. doi: 10.3346/jkms.2023.38.e212.
3
Perioperative blood usage and therapeutic plasma exchange in kidney transplantation during a 16-year period in South Korea.韩国 16 年间肾移植围手术期的血液使用和治疗性血浆置换情况。
Blood Transfus. 2021 Mar;19(2):102-112. doi: 10.2450/2020.0050-20. Epub 2020 Jun 10.
4
Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.输注白细胞滤除的血液制品与肾移植受者抗体介导性排斥反应的风险
Transfusion. 2018 Aug;58(8):1951-1957. doi: 10.1111/trf.14800. Epub 2018 Sep 1.
5
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases.输血对结直肠癌肝转移患者肝切除术后围手术期及长期预后的影响。
Ann Surg. 2003 Jun;237(6):860-9; discussion 869-70. doi: 10.1097/01.SLA.0000072371.95588.DA.
6
Serological findings and efficiency of DNA profiling in transfused patients and their significance for identity and paternity tests.输血患者的血清学检查结果及DNA分析效率及其在身份鉴定和亲子鉴定中的意义。
Int J Legal Med. 1994;106(4):178-82. doi: 10.1007/BF01371333.
本文引用的文献
1
2
3
Serological studies in patients on platelet- and granulocyte-substitution therapy.接受血小板和粒细胞替代疗法患者的血清学研究。
Br J Haematol. 1982 Sep;52(1):59-68. doi: 10.1111/j.1365-2141.1982.tb03861.x.
4
5
The preparation of leukocyte-poor red cells for transfusion by a simple cost-effective technique.
Transfusion. 1984 Nov-Dec;24(6):508-9. doi: 10.1046/j.1537-2995.1984.24685066812.x.
6
Role of microaggregate blood filtration in clinical medicine.
Transfusion. 1983 Nov-Dec;23(6):460-70. doi: 10.1046/j.1537-2995.1983.23684074264.x.
7
Transfusion therapy and HLA antibody response in patients undergoing open heart surgery.
Transfusion. 1982 Jul-Aug;22(4):320-2. doi: 10.1046/j.1537-2995.1982.22482251219.x.
8
Immunological aspects of platelet transfusions.
Br J Haematol. 1985 Jul;60(3):409-14. doi: 10.1111/j.1365-2141.1985.tb07437.x.
9
Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.使用少白细胞血液成分和 HLA 匹配的血小板供体预防 HLA 同种免疫。
Br J Haematol. 1986 Mar;62(3):529-34. doi: 10.1111/j.1365-2141.1986.tb02965.x.
10
Alloimmunisation to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions.
Vox Sang. 1985;49(5):331-5. doi: 10.1111/j.1423-0410.1985.tb00807.x.
Zotero 插件